Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghenadie MordvinovfiledCriticalGhenadie Mordvinov
Priority to MD99-0282ApriorityCriticalpatent/MD1505G2/en
Publication of MD1505F1publicationCriticalpatent/MD1505F1/en
Publication of MD1505G2publicationCriticalpatent/MD1505G2/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The invention relates to medicine and is provided for treatment of patients with rheumatoid affections. The preparation for treatment of rheumatoid affections comprises aggregated human G immunoglobulin in the form of a 10% aqueous solution. The result of the invention consists in the inhibition of the rheumatoid factor synthesis. Claims: 2
MD99-0282A1999-12-171999-12-17Preparation for treatment of rheumatoid affections
MD1505G2
(en)
Use of L-carnitine and acyl-L-carnitine for the treatment of patients suffering from AIDS-related syndromes and of asymptomatic HIV-seropositive patients